Looking to publish in Diabetes Technology & Therapeutics? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginThis peer-reviewed journal provides healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes.
Looking to publish in Diabetes Technology & Therapeutics? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Diabetes Technology & Therapeutics accepts the following article types. Click on an article type to view submission instructions.
Original Articles
Review Articles
Brief Reports
Letters To The Editor
Observational Letter
Recent Publications
Efficacy and Safety of the MiniMed™ Vivera™ Algorithm: Results from a First-in-Human Feasibility Trial
Amir Tirosh, Benjamin J. Wheeler, Maya Laron Hirsh, Ella Idan, Yael Cohen, Alisa Boucsein, Wipa Warunyuwong, Natalie Kurtz, Magaly Juarez, Anirban Roy, Benyamin Grosman, Ohad Cohen
Association of HbA1c with Time in Range, Time in Tight Range, Empirically Derived Continuous Glucose Monitoring Glucose Ranges, and Mean Glucose
Halis Kaan Akturk, Kagan E. Karakus, Emma Mason, Zeynep Y. Yilmaz, Satish K. Garg, Dicle Cengiz
Pediatric Inpatient Continuous Glucose Monitoring: Development and Implementation of a Hospital Policy for Accuracy-Validated Insulin Dosing
Ming Yeh Lee, Hector I. Ortega, Christopher Chow-Parmer, Karen Belanger, Sheridan Jones, Victor Ritter, Whitney Chadwick, Julie J. Lee, Kailee Kingston, Cristal Suarez, Mark McGovern, David M. Maahs, Priya Prahalad, Sejal Shah, Rayhan Lal, Michael S. Hughes
Letter: “Natural History of Mild Non-Proliferative Diabetic Retinopathy in Adults with Type 1 Diabetes Under Contemporary Diabetes Care”
Ervic R. Cabading, Mary Jane S. Alejo
Roadmap to Fully Closing the Loop to Optimize Health in Type 1 Diabetes
Brynn E. Marks, Marisa E. Hilliard, Boris Kovatchev, Othmar Moser, Molly L. Tanenbaum, Courtney Ackeifi, David T. Ahn, Ramzi A. Ajjan, Anastasia Albanese-O’Neill, Abdulmohsen Bakhsh, Pratik Choudhary, Kelly L. Close, Elizabeth A. Davis, Klemen Dovc, Sanjoy Dutta, Satish Garg, Gregory P. Forlenza, Julie Heverly, Aaron J. Kowalski, Catarina Limbert, David M. Maahs, Julia K. Mader, Marjana Marinac, Chantal Mathieu, Revital Nimri, Rimei Nishimura, David N. O’Neal, Monica Oxenreiter, Chengyuan Press, Michael R. Rickels, Michael C. Riddell, Jonathan Rosen, Banshi Saboo, Viral N. Shah, Jennifer L. Sherr, Benjamin J. Wheeler, Moshe Phillip, Tadej Battelino, Thomas Danne
Frequently asked questions
How long does it take to publish?
Prompt publishing.
Reformat to Diabetes Technology & Therapeutics using Livewrite PremiumIs a cover letter required?
A covering letter is required when writing or editing assistance from a third party is disclosed, when a submission is made on behalf of the authors by a non-author, and a confirmatory letter may be uploaded for consent to publish information.
Reformat to Diabetes Technology & Therapeutics using Livewrite PremiumWhat are the publication costs?
Mandatory page charges are $90/page upon acceptance. Optional open access publishing is available for a fee via Sage Choice.
Reformat to Diabetes Technology & Therapeutics using Livewrite Premium